Kura Oncology (KURA) Misses Q2 EPS by 34c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.75), $0.34 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $15.3 million versus the consensus estimate of $39.11 million.

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Crude Inventory Fell 4.5M Barrels Last Week - EIA
• Marriott (MAR) call put ratio 2.6 calls to 1 put with a focus on October puts and January 400 calls
• Wynn Resorts Ltd (WYNN) call put ratio 1 call to 1 put as share price up 2.3%